Figure 5
Figure 5. Acute leukemia in MllPTD/WT:Flt3ITD/ITD mice. (A) Only AML and B-cell leukemias developed in MllPTD/WT:Flt3ITD/ITD mice. Nineteen mice were analyzed. (B) MllPTD/WT:Flt3ITD/ITD mice with leukemia exhibited significant splenomegaly at time of death. (C) WBC counts (median ± SEM) for leukemic MllPTD/WT:Flt3ITD/ITD and age-matched control genotypes at the time of death. (D) MllPTD/WT:Flt3ITD/ITD mice died of AML with a significantly shorter latency than MllPTD/WT:Flt3ITD/WT mice. (E) Copy number ratio of Mll-WT:Mll-PTD was calculated for age-matched nonleukemic 15- to 25-week-old MllPTD/WT:Flt3ITD/WT and leukemic MllPTD/WT:Flt3ITD/ITD mice. Results are representative of 2 age-matched cohorts of mice.

Acute leukemia in MllPTD/WT:Flt3ITD/ITD mice. (A) Only AML and B-cell leukemias developed in MllPTD/WT:Flt3ITD/ITD mice. Nineteen mice were analyzed. (B) MllPTD/WT:Flt3ITD/ITD mice with leukemia exhibited significant splenomegaly at time of death. (C) WBC counts (median ± SEM) for leukemic MllPTD/WT:Flt3ITD/ITD and age-matched control genotypes at the time of death. (D) MllPTD/WT:Flt3ITD/ITD mice died of AML with a significantly shorter latency than MllPTD/WT:Flt3ITD/WT mice. (E) Copy number ratio of Mll-WT:Mll-PTD was calculated for age-matched nonleukemic 15- to 25-week-old MllPTD/WT:Flt3ITD/WT and leukemic MllPTD/WT:Flt3ITD/ITD mice. Results are representative of 2 age-matched cohorts of mice.

Close Modal

or Create an Account

Close Modal
Close Modal